XM does not provide services to residents of the United States of America.
I
I

Ipsen

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

European shares end marginally lower on tech drag; Fed in focus

UPDATE 2-European shares end marginally lower on tech drag; Fed in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window France's Rexel jumps after rejecting $9.4 bln QXO bid UK insurer Phoenix falls on halting sale of unit SunLife STOXX 600 down 0.2% Updated at 1600 GMT By Shubham Batra and Shashwat Chauhan Sept 16 (Reuters) - Europe's STOXX 600 closed slightly lower on Monday as losses in heavyweight technology shares weighed on the in
C
I
N
P
R
U
H
E
F
U
G

Tepid start for STOXX as miners weigh

LIVE MARKETS-Tepid start for STOXX as miners weigh STOXX 600 up 0.1% Miners down after China data M&A activity provides lifts Week's cenbank meetings loom Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com TEPID START FOR STOXX AS MINERS WEIGH The STOXX 600 .STOXX has kicked off the week hovering around flat, last up 0.1% after mostly flashing red for the first hour of trading.
I
P
R
E
F
U
G

Ipsen rises after RBC ups on Iqirvo U.S. approval

BUZZ-Ipsen rises after RBC ups on Iqirvo U.S. approval ** Shares in Ipsen IPN.PA rise around 5% after RBC upgraded the French biopharma company to "outperform" from "sector perform", seeing mid-term support from Iqirvo (PBC) after its U.S. FDA approval in June ** The broker now sees peak sales for the primary biliary cholangiti treatment at 540 mil
I

MTU Aero Engines, Nestle, Vusiongroup

EUROPE RESEARCH ROUNDUP- MTU Aero Engines, Nestle, Vusiongroup Sept 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including MTU Aero Engines, Nestle and Vusiongroup, on Monday. HIGHLIGHTS * Advanced Medical Solutions Group Plc AMSU.L : Peel Hunt raises target to 246p from 220p * MTU Aero Engines AG MTXGn.DE : Citigroup cuts to sell from neutral * Nestle SA NESN.S : Morgan Stanley cuts to underweight from equal-weight * Sodexo EXHO.PA : B
A
A
B
B
C
D
I
I
M
M
N
N
S
A
A
P

Ipsen Provides Update On Contact-02 Phase III Trial

BRIEF-Ipsen Provides Update On Contact-02 Phase III Trial Sept 15 (Reuters) - Ipsen SA IPN.PA : IPSEN PROVIDES UPDATE ON CONTACT-02 PHASE III TRIAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER FOLLOWING FINAL OVERALL SURVIVAL ANALYSIS IPSEN - TRIAL DEMONSTRATED A POSITIVE TREND TOWARDS IMPROVEMENT FOR ONE OF PRIMARY ENDPOINTS, BUT DID NOT MEE
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.